author-photo

Asha Das

Genentech

39

Papers

723

Citations

Citation Trend

Filter By

Papers (34) Sort By

Journal Conference Others

10 Toca 5: Toca 511 combined with Toca FC versus standard of care in patients undergoing planned resection for recurrent glioblastoma or anaplastic astrocytoma

2018 Canadian Journal of Neurological Sciences
Show All
- Source
- Cite
- Save
Citations (1)
Abstract A085: Durable responses observed in recurrent high-grade glioma (rHGG) with Toca 511 and Toca FC treatment

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
Durable complete responses in some recurrent high-grade glioma patients treated with Toca 511 + Toca FC

2018 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (81)
25 Durable complete responses observed in patients with recurrent high grade glioma treated with Toca 511 & Toca FC

2018 Canadian Journal of Neurological Sciences
Show All
- Source
- Cite
- Save
Citations (0)
Treatment of recurrent hgg patients with the retroviral replicating vector Toca 511 and Toca FC gives durable responses and survival lasting 3 years or longer: Immune mechanisms and molecular analyses of tumors

2018
Show All
- Source
- Cite
- Save
Citations (0)
Toca 511 & Toca FC: Evaluation of Durable Response Rate in the Post-Resection Setting and Association with Survival in Patients with Recurrent High Grade Glioma (S23.006)

2018 Neurology
Show All
- Source
- Cite
- Save
Citations (0)
Durable responses observed in recurrent high-grade glioma (rHGG) with Toca 511 and Toca FC treatment

2018
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 5630: Immune profile of tumor microenvironment helps predict response in patients treated with an investigational immunotherapeutic consisting of a retroviral replicating vector (Toca 511) and an extended-release formulation of 5-fluorocytosine (Toca FC)

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Durable complete responses observed in IDH1 mutated high grade glioma at first recurrence undergoing treatment with Toca 511 and Toca FC.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
ATIM-02. DURABLE RESPONSES OBSERVED IN IDH1 WILDTYPE AND MUTANT RECURRENT HIGH GRADE GLIOMA (rHGG) WITH TOCA 511 & TOCA FC TREATMENT

2017 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)